Efficacy and Safety of Heavy Silicone Oil Densiron 68 in the Treatment of Complicated Retinal Detachment with Large Inferior Retinectomy

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2008 Jul 1

PMID 18587596

Citations 18

Authors

Sylvain Auriol

Veronique Pagot-Mathis

Laurence Mahieu

Claudia Lemoine

Andre Mathis

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the efficacy and safety of a heavy silicone oil (Densiron 68 a mixture of perfluorohexyloctane (F(6)H(8)) with silicone oil as temporary internal tamponade in selected retinal detachments treated with large inferior retinectomy.

Methods: Complicated retinal detachments with severe posterior and anterior proliferative vitreoretinopathy (PVR) were included in this study. In all cases, a large inferior retinectomy involving the inferior quadrants was performed. Densiron 68 was injected at the end of surgery after perfluorocarbon injection. A minimum follow-up of 6 months was required in order to be included in this retrospective study.

Results: Twenty-seven patients were operated on with a mean follow-up of 57.5 weeks. Twenty-three patients presented a posterior PVR > CP6 and 26 patients an anterior PVR > CA5. Heavy silicone oil was removed in 19 patients after a mean follow-up of 14 weeks. At the 4-week follow-up visit, only one retinectomy was reopened by a recurrent inferior retinal detachment with PVR CP3. Finally, anatomical success was achieved in 25 of the 27 patients (92.5%) after Densiron 68 removal at the last follow-up. The main adverse effect was inflammatory reaction with fibrin accumulation in the anterior chamber (40.7%).

Conclusion: Densiron 68 appeared to be an efficient endotamponade agent in selected retinal detachments treated with large inferior retinectomy. It avoids fluid accumulation under the inferior retina and seems to limit the rate of inferior retinectomy reopening.

Citing Articles

An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy.

Hammer M, Ie A, Eibenberger K, Auffarth G, Xue K BMC Ophthalmol. 2025; 25(1):38.

PMID: 39844136 PMC: 11756122. DOI: 10.1186/s12886-024-03834-7.

Retrospective case series of high-density silicone oil (Oxane HD) in severe proliferative vitreorretinal retinal detachment patients.

Oliveira R, Pesquero V, Ribeiro L, Polizelli M, Silva A, de Moraes N Int J Retina Vitreous. 2024; 10(1):33.

PMID: 38605358 PMC: 11007898. DOI: 10.1186/s40942-024-00548-2.

Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery.

Confalonieri F, Josifovska N, Boix-Lemonche G, Stene-Johansen I, Bragadottir R, Lumi X Int J Mol Sci. 2023; 24(4).

PMID: 36834754 PMC: 9961686. DOI: 10.3390/ijms24043342.

Short-Term Total Tamponade with Perfluorocarbon Liquid and Silicone Oil in Complex Rhegmatogenous Retinal Detachment with Severe Proliferative Vitreoretinopathy.

Trabelsi O, Bouladi M, Ouertani A, Trabelsi A Clin Ophthalmol. 2023; 17:515-525.

PMID: 36789290 PMC: 9922565. DOI: 10.2147/OPTH.S400156.

Heavy silicone oil tamponade: a multicentre experience.

Davidson M, Dowlut S, Zhang J, Naderi K, Sandinha T, Wood M BMJ Open Ophthalmol. 2023; 7(1).

PMID: 36710637 PMC: 9743375. DOI: 10.1136/bmjophth-2022-001018.

References

Morse L, McCuen 2nd B, MACHEMER R . Relaxing retinotomies. Analysis of anatomic and visual results. Ophthalmology. 1990; 97(5):642-7; discussion 647-8. View

Yeo J, Glaser B, Michels R . Silicone oil in the treatment of complicated retinal detachments. Ophthalmology. 1987; 94(9):1109-13. DOI: 10.1016/s0161-6420(87)33328-7. View

Kampik A, Hoing C, Heidenkummer H . Problems and timing in the removal of silicone oil. Retina. 1992; 12(3 Suppl):S11-6. DOI: 10.1097/00006982-199212031-00004. View

Camacho H, Bajaire B, Mejia L . Silicone oil in the management of giant retinal tears. Ann Ophthalmol. 1992; 24(2):45-9. View

MACHEMER R, AABERG T, Freeman H, IRVINE A, Lean J, Michels R . An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991; 112(2):159-65. DOI: 10.1016/s0002-9394(14)76695-4. View

Theelen T, Tilanus M, Klevering B . Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol. 2004; 242(7):617-20. DOI: 10.1007/s00417-004-0898-7. View

Jonas J, Budde W, Knorr H . Timing of retinal redetachment after removal of intraocular silicone oil tamponade. Am J Ophthalmol. 1999; 128(5):628-31. DOI: 10.1016/s0002-9394(99)00201-9. View

McCuen 2nd B, Landers 3rd M, MACHEMER R . The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy. Ophthalmology. 1985; 92(8):1029-34. DOI: 10.1016/s0161-6420(85)33904-0. View

Abrams G, Azen S, McCuen 2nd B, Flynn Jr H, Lai M, Ryan S . Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol. 1997; 115(3):335-44. DOI: 10.1001/archopht.1997.01100150337005. View

10.

van Meurs J, Mertens D, Peperkamp E, Post J . Five-year results of vitrectomy and silicone oil in patients with proliferative vitreoretinopathy. Retina. 1993; 13(4):285-9. DOI: 10.1097/00006982-199313040-00003. View

11.

Pagot-Mathis V, Benouaich X, Mathis A, Rico-Lattes I, Dumoulin A . [Management of complicated retinal detachment using a heavy silicon oil as temporary tamponade]. J Fr Ophtalmol. 2006; 29(2):137-45. DOI: 10.1016/s0181-5512(06)73761-5. View

12.

Gonvers M . Temporary use of silicone oil in the treatment of special cases of retinal detachment. Ophthalmologica. 1983; 187(4):202-9. DOI: 10.1159/000309327. View

13.

Sell C, McCuen 2nd B, Landers 3rd M, MACHEMER R . Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol. 1987; 103(1):24-8. DOI: 10.1016/s0002-9394(14)74164-9. View

14.

Sandner D, Engelmann K . First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2005; 244(5):609-19. DOI: 10.1007/s00417-005-0110-8. View

15.

Rizzo S, Belting C, Genovesi-Ebert F, Cresti F, Vento A, Martini R . Successful treatment of persistent macular holes using "heavy silicone oil" as intraocular tamponade. Retina. 2006; 26(8):905-8. DOI: 10.1097/01.iae.0000250006.76155.3d. View

16.

McCuen 3rd B, de Juan Jr E, MACHEMER R . Silicone oil in vitreoretinal surgery. Part 1: Surgical techniques. Retina. 1985; 5(4):189-97. DOI: 10.1097/00006982-198500540-00001. View

17.

Capone Jr A, AABERG T . Silicone oil in vitreoretinal surgery. Curr Opin Ophthalmol. 1995; 6(3):33-7. DOI: 10.1097/00055735-199506000-00006. View

18.

Wolf S, Schon V, Meier P, Wiedemann P . Silicone oil-RMN3 mixture ("heavy silicone oil") as internal tamponade for complicated retinal detachment. Retina. 2003; 23(3):335-42. DOI: 10.1097/00006982-200306000-00008. View

19.

Wiedemann P, Hilgers R, Bauer P, Heimann K . Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol. 1998; 126(4):550-9. DOI: 10.1016/s0002-9394(98)00115-9. View

20.

Scholda C, Egger S, Lakits A, Haddad R . Silicone oil removal: results, risks and complications. Acta Ophthalmol Scand. 1998; 75(6):695-9. DOI: 10.1111/j.1600-0420.1997.tb00633.x. View